Barclays PLC Bio Affinity Technologies, Inc. Call Options Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BIAF
# of Institutions
19Shares Held
583KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA177KShares$51,3000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA125KShares$36,3830.0% of portfolio
-
Allworth Financial LP53.7KShares$15,5820.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$15,5820.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$8,0860.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $791K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...